山东大学耳鼻喉眼学报 ›› 2017, Vol. 31 ›› Issue (2): 49-54.doi: 10.6040/j.issn.1673-3770.0.2017.017

• 论著 • 上一篇    下一篇

靶向c-Met嵌合抗原受体T细胞的制备及其对鼻咽癌细胞作用的研究

周荧1,徐亚如2,黄骁辰2,陈渊1,章明炯2,张大为1,唐奇2,朱进3,陈仁杰1   

  1. 1.南京医科大学第二附属医院耳鼻喉科, 江苏 南京 210011;
    2.南京医科大学卫生部抗体技术重点实验室, 江苏 南京 210029;
    3.南京军区军事医学研究所, 江苏 南京 210002
  • 收稿日期:2017-01-11 出版日期:2017-04-16 发布日期:2017-04-16
  • 通讯作者: 陈仁杰. E-mail:renjiechenent@aliyun.com
  • 基金资助:
    江苏省科技厅临床医学科技专项计划(BL2013038);国家青年科学基金资助项目(81502673)

Construction of c-Met target chimeric antigen receptor T cells and evaluation the role on nasopharyngeal carcinoma cells.

  1. 1. Deparment of Otolaryngology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, Jiangsu, China;2. Key Laboratory of Antibody Technique of Ministry of Health, Nanjing Medical University, Nanjing 210029, Jiangsu, China;3. Medical Research Institute of Nanjing Military Region, Nanjing 210002, Jiangsu, China
  • Received:2017-01-11 Online:2017-04-16 Published:2017-04-16

摘要: 目的 构建靶向c-Met的嵌合抗原受体(CAR)逆转录病毒载体,制备靶向c-Met CAR-T,观察其对c-Met阳性鼻咽癌细胞的杀伤作用。 方法 利用基因工程技术构建抗c-Met scFv,并将其重组到含有CD28,CD137,CD3ζ等的逆转录病毒载体中,形成c-Met CAR逆转录病毒载体,测序确认。以该病毒载体感染T淋巴细胞,通过Western blotting检测c-MetCAR在T淋巴细胞中的表达。CCK-8检测c-Met CAR-T对鼻咽癌细胞的作用;通过ELISA检测c-Met CAR-T作用后IFN-γ、IL-2的变化。 结果 测序结果显示c-Met CAR病毒载体序列正确;Western blotting可检测到CD3ζ的表达;CCK-8结果显示,c-Met CAR-T明显抑制c-Met阳性的鼻咽癌细胞的增殖(P<0.05);ELISA结果显示,c-Met CAR-T作用后分泌IFN-γ、IL-2明显增加(P<0.01)。 结论 成功制备了靶向c-Met的嵌合抗原受体逆转录病毒载体。该嵌合抗原受体能在T细胞中表达,能有效抑制c-Met阳性鼻咽癌细胞增殖,增加IFN-γ、IL-2的分泌。

关键词: 鼻咽肿瘤, c-Met, 嵌合抗原受体

Abstract: Objective To construct c-Met target chimeric antigen receptors(chimeric antigen receptor, CAR)retrovirus vector and to explore its expression and effects of modified T lymphocytes on the c-Met positive nasopharyngeal carcinoma cells. Methods Genetic engineering method was used to construct the c-Met scFv, and then the c-Met scFv was inserted into retrovirus vector containing signaling molecules such as CD28, CD137 and CD3ζ.The build c-Met CAR retrovirus vector was confirmed by sequencing. Western blotting was used to analyze c-Met CAR expression in T lymphocyte after the virus vector infected T lymphocyte. CCK8 assay was employed to detect the cytotoxicity against the nasopharyngeal carcinoma cell lines, and changes of IFN-γ and IL-2 was analyzed by ELISA after c-Met CAR-T co-culture with nasopharyngeal carcinoma cells. Results The sequencing result showed that the c-Met CAR vector sequences were right. Western blotting could detect the expression of CD3ζ. CCK-8 assay indicated that c-Met CAR-T cells suppressed proliferation of nasopharyngeal carcinoma cells, and ELISA assay demonstrated that c-Met CAR-T cells could effectively release IFN-γ and IL-2 with the help of nasopharyngeal carcinoma cells. Conclusion c-Met CAR retrovirus vector was established successfully. The CAR could be expressed by the vector in T cells. c-Met CAR-T inhibited proliferation of c-Met positive nasopharyngeal carcinoma cells and increased the secretion of IFN-γ and IL-2.

Key words: Nasopharyngeal carcinoma, c-Met, Chimeric antigen receptor

中图分类号: 

  • R739.62
[1] 刘孟忠. 鼻咽癌治疗新进展[J]. 广东医学, 2014, 35(1):1-4.
[2] 张煜, 封青, 胡军. 肿瘤的细胞免疫治疗研究进展[J]. 生物技术通讯, 2012, 23(3):440-443. ZHANG Yu, FENG Qing, HU Jun. Research progress on cellular immunotherapy for tumor[J]. Lett Biotechnol, 2012, 23(3):440-443.
[3] Sadelain M, Brentjens R, Riviere I. The basic principles of chimeric antigen receptor design[J]. Cancer Discov, 2013, 3(4):388-398.
[4] Morello A, Sadelain M, Adusumilli PS. Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors[J]. Cancer Discov, 2016, 6(2):133-146.
[5] Luan T, Yu Y. Increased hepatocyte growth factor and c-Met receptor expression in nasopharyngeal carcinoma[J]. Int J Clin Exp Med, 2014, 7(12):5583-5587.
[6] Toiyama Y, Yasuda H, Saigusa S, et al. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer[J]. Int J Cancer, 2012, 130(12):2912-2921.
[7] 刘崇梅, 于惠芝, 林明晖, 等. HGF/c-Met系统在鼻咽癌中的表达及其与增殖细胞核抗原的关系[J]. 现代肿瘤医学,2009,17(11):2087-2090. LIU Chongmei, YU Huizhi, LIN Minghui, et al. Expression of HGF/c-Met system and its relationship with expression of PCNA in nasopharyngeal carcinoma[J]. J Mod Oncol, 2009, 17(11):2087-2090.
[8] 白璐月,刘金荣,唐奇,等. 人源全分子抗c-Met抗体的制备及对鼻咽癌细胞生物学特性的影响[J]. 南京医科大学学报(自然科学版), 2016, 36(6):687-692. BAI Luyue, LIU Jinrong, TANG Qi, et al. Preparation of full molecule human anti-c-Met antibody and its effects on nasopharyngeal carcinoma cells[J]. Acta Univ Med Nanjing(Natural Sci), 2016, 36(6):687-692.
[9] Jena B, Dotti G, Cooper LJ. Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor[J]. Blood, 2010, 116(7):1035-1044.
[10] Whilding LM, Maher J. ErbB-targeted CAR T-cell immunotherapy of cancer[J]. Immunotherapy, 2015, 7(3):229-241.
[11] Turtle CJ, Riddell SR, Maloney DG. CD19-targeted chimeric antigen receptor-modified T cell immunotherapy for B cell malignancies[J]. Clin Pharmacol Ther, 2016, 100(3):252-258.
[12] Katz SC, Burga RA, McCormack E, et al. Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases[J]. Clin Cancer Res, 2015, 21(14):3149-3159.
[13] Lamers CH, Sleijfer S, van Steenbergen S, et al. Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T cells: clinical evaluation and management of on-target toxicity[J]. Mol Ther, 2013, 21(4):904-912.
[14] Louis CU, Savoldo B, Dotti G, et al. Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma[J]. Blood, 2011, 118(23):6050-6056.
[1] 杜志宏. 电子鼻咽镜下口鼻联合径路在鼻咽部活检中的应用[J]. 山东大学耳鼻喉眼学报, 2017, 31(4): 117-118.
[2] 刘叶,孙殿水,殷进军,夏明,徐英,孙建华. 鼻咽癌调强放疗后前庭功能损伤的机制研究[J]. 山东大学耳鼻喉眼学报, 2016, 30(6): 14-17.
[3] 唐隽, 施思斯, 于青青, 萧建新, 张超. 鼻咽癌放疗后继发慢性鼻窦炎的临床特征[J]. 山东大学耳鼻喉眼学报, 2015, 29(2): 52-54.
[4] 石大志1, 李建明2,罗志强1,罗琴1,敬前程1. 妊娠期鼻咽恶性肿瘤临床分析[J]. 山东大学耳鼻喉眼学报, 2014, 28(3): 28-30.
[5] 张小鹏1,边枫2,王丽新2. 环氧合酶-2及表皮生长因子受体在鼻咽癌中的表达及相关性[J]. 山东大学耳鼻喉眼学报, 2014, 28(3): 23-27.
[6] 杜晓东,宋红毛,马美,徐桂容,舒畅,程冯. 双管置入治疗鼻咽癌放疗后分泌性中耳炎[J]. 山东大学耳鼻喉眼学报, 2011, 25(4): 36-.
[7] 包伟晶,林昶,李志春. 光催化纳米TiO2治疗鼻咽癌基础研究[J]. 山东大学耳鼻喉眼学报, 2011, 25(2): 68-.
[8] 刘蓉蓉,姬长友,陈继川. 重组人p53腺病毒注射液(今又生)联合放疗治疗复发性鼻咽癌疗效观察[J]. 山东大学耳鼻喉眼学报, 2010, 24(5): 13-16.
[9] 朱国臣,张永胜,郑晓彬,肖大江. 乙酰肝素酶、nm23-H1在鼻咽癌中的表达以及与侵袭转移的关系[J]. 山东大学耳鼻喉眼学报, 2010, 24(4): 30-33.
[10] 陈洽鑫 综述 张志钢 郑亿庆 审校. 放射性分泌性中耳炎[J]. 山东大学耳鼻喉眼学报, 2009, 23(4): 35-37.
[11] 李军政,江东新,陈伟南,焦文成,高翔,黄佩仪,梁悦浓,陈文弦. 鼻内镜下咽鼓管置管治疗鼻咽癌放疗后分泌性中耳炎[J]. 山东大学耳鼻喉眼学报, 2009, 23(3): 15-16.
[12] 李海英,刘韶平,刘芳
. 鼻咽癌放疗后颈部残余淋巴结超声检查
与病理活检的对照
[J]. 山东大学耳鼻喉眼学报, 2009, 23(2): 12-14 .
[13] 吉文婷综述, 殷善开, 陈斌审校
. 鼻咽癌放疗后耳鼻咽喉科常见并发症的诊疗原则[J]. 山东大学耳鼻喉眼学报, 2009, 23(1): 36-39 .
[14] 雷迅1 ,刘强和1 ,孔中雨1 ,向秋2 ,耿宛平1 ,黄辉3 ,董译元1 ,刘芳贤1
. EGCG对鼻咽癌细胞株裸鼠移植瘤的放疗增敏作用以及对Survivin表达的影响[J]. 山东大学耳鼻喉眼学报, 2009, 23(1): 6-9 .
[15] 程金妹,谢振宇,林 勤,张鹏飞,林 英,易自翔,田为中 . 抑癌基因PTEN在鼻咽癌中的表达及突变[J]. 山东大学耳鼻喉眼学报, 2008, 22(5): 405-407 .
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 赵利敏,倪坤,吴佳丽,陈淑梅,李晓艳. 婴幼儿吸气性喉喘鸣病因分析与治疗[J]. 山东大学耳鼻喉眼学报, 2013, 27(2): 49 -51 .
[2] 史春生1,张庆泉2,王强2,孙岩2,葛长艺1. 软腭缺损修复组织瓣的特点[J]. 山东大学耳鼻喉眼学报, 2013, 27(2): 86 -88 .
[3] 张令1,孙传义1,许安廷2. 以耳聋就诊的岩尖胆脂瘤1例[J]. 山东大学耳鼻喉眼学报, 2013, 27(2): 93 -94 .
[4] 吴彦桥,邸斌,李军,高晓红 . 鼻内镜下难治性鼻出血出血点寻找及止血策略[J]. 山东大学耳鼻喉眼学报, 2013, 27(4): 1 -3 .
[5] 罗惠秀,范春涛,邓延华. 阻塞性睡眠呼吸暂停低通气综合征患儿扁桃体腺样体切除术临床疗效分析[J]. 山东大学耳鼻喉眼学报, 2013, 27(4): 17 -20 .
[6] 郝颖娟1,杨庆松2,周跃华2,易省平1,翟长斌2. 飞秒激光在薄瓣LASIK手术中制作的角膜瓣厚度形态观察[J]. 山东大学耳鼻喉眼学报, 2013, 27(4): 26 -31 .
[7] 闻华明1,李海祥2. 应用三角函数法估算LASIK术后人工晶状体度数[J]. 山东大学耳鼻喉眼学报, 2013, 27(5): 74 -76 .
[8] 朱见,贺青卿,郑鲁明,范子义,赵国伟,侯蕾,史后彬 . cN0甲状腺微小乳头状癌淋巴结转移高危因素及行预防性清扫临床分析[J]. 山东大学耳鼻喉眼学报, 2013, 27(6): 9 -12 .
[9] 李少华,孙一帆,卢标清. 双软组织血管瓣填塞乳突术腔的临床研究[J]. 山东大学耳鼻喉眼学报, 2014, 28(1): 6 -7 .
[10] 魏希建1,阴瑞兰2,郭星3. 增殖诱导配体在喉鳞状细胞癌中的表达[J]. 山东大学耳鼻喉眼学报, 2014, 28(1): 14 -16 .